CK Life Sciences International Holdings (FRA:LSI) Market Cap: €636.6 Mil (As of Jun. 27, 2026)


FRA:LSI CK Life Sciences International Holdings Inc FRA:LSI
34 GF Score
Price €0.06
GF Value €0.08
! 5 Warning Signs
View Full Analysis

What is CK Life Sciences International Holdings Market Cap?

CK Life Sciences International Holdings FRA:LSI -1.54% 34 Market Cap is €636.6 Mil as of Jun. 27, 2026. GuruFocus rates FRA:LSI with a GF Score™ of 34/100 and a GF Value™ of €0.08. The stock has 5 warning signs investors should review. Among 1,431 Biotechnology companies, CK Life Sciences International Holdings ranks better than 76.59% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). CK Life Sciences International Holdings's share price for the quarter that ended in Dec. 2025 was €0.0875. CK Life Sciences International Holdings's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 9,611.1 Mil. Therefore, CK Life Sciences International Holdings's market cap for the quarter that ended in Dec. 2025 was €841.0 Mil.

CK Life Sciences International Holdings's quarterly market cap increased from Dec. 2024 (€427.7 Mil) to Jun. 2025 (€879.4 Mil) but then declined from Jun. 2025 (€879.4 Mil) to Dec. 2025 (€841.0 Mil).

CK Life Sciences International Holdings's annual market cap declined from Dec. 2023 (€634.3 Mil) to Dec. 2024 (€427.7 Mil) but then increased from Dec. 2024 (€427.7 Mil) to Dec. 2025 (€841.0 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. CK Life Sciences International Holdings's Enterprise Value for Today is €1,319.5 Mil.


CK Life Sciences International Holdings  (FRA:LSI) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


CK Life Sciences International Holdings Market Cap Related Terms


CK Life Sciences International Holdings Market Cap Historical Data

* Premium members only.

The historical data trend for CK Life Sciences International Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CK Life Sciences International Holdings Market Cap Chart

CK Life Sciences International Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 759.27 869.80 634.33 427.69 840.97

CK Life Sciences International Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 634.33 317.17 427.69 879.41 840.97

FRA:LSI vs VRTX, REGN, ALNY: Market Cap Comparison

For the Biotechnology subindustry, CK Life Sciences International Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CK Life Sciences International Holdings Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where CK Life Sciences International Holdings's Market Cap falls into.


FRA:LSI
34GF Score
CK Life Sciences International Holdings Inc FRA:LSI
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CK Life Sciences International Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

CK Life Sciences International Holdings's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=€0.0875*9611.073
=€841.0

CK Life Sciences International Holdings's Market Cap for the quarter that ended in Dec. 2025 is calculated as

Market Cap (Q: Dec. 2025 )=Share Price (Q: Dec. 2025 )*Shares Outstanding (EOP) (Q: Dec. 2025 )
=€0.0875*9611.073
=€841.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of €636.6 Mil mean?
CK Life Sciences International Holdings (FRA:LSI) has a Market Cap of €636.6 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on CK Life Sciences International Holdings and its competitors. According to the industry distribution chart, CK Life Sciences International Holdings ranks #335 out of 1431 companies in the Biotechnology industry, placing it in the top 23.4%.
Is CK Life Sciences International Holdings' Market Cap too high?
CK Life Sciences International Holdings' current Market Cap is €636.6 Mil. Based on the distribution chart, CK Life Sciences International Holdings ranks #335 out of 1431 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, CK Life Sciences International Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does CK Life Sciences International Holdings' Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CK Life Sciences International Holdings ranks #335 out of 1431 companies for Market Cap. This places CK Life Sciences International Holdings in the top 23% of its industry — outperforming the majority of peers. The industry median Market Cap is 113.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 113.83, based on 1,431 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on CK Life Sciences International Holdings and its competitors. For the Biotechnology industry, the median Market Cap is 113.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CK Life Sciences International Holdings's current Market Cap is €636.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CK Life Sciences International Holdings stock overvalued right now?
CK Life Sciences International Holdings (FRA:LSI) has a current Market Cap of €636.6 Mil. The stock's GF Value™ is €0.08, compared to a current price of €0.06 — trading 20% below its estimated fair value. The current Market Cap is €636.6 Mil. CK Life Sciences International Holdings' overall GF Score™ is 34/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For CK Life Sciences International Holdings (FRA:LSI), the current Market Cap is €636.6 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CK Life Sciences International Holdings (FRA:LSI) Overvalued in 2026?

Based on GuruFocus' analysis, CK Life Sciences International Holdings stock appears to be undervalued. The current stock price of €0.06 is trading 20% below its estimated GF Value™ of €0.08.

Key valuation signals for FRA:LSI:

  • Market Cap: €636.6 Mil
  • GF Value™: €0.08 vs. price of €0.06 (20% below fair value)
  • GF Score™: 34/100 with 5 warning signs

No single metric tells the full story. See the FRA:LSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CK Life Sciences International Holdings Business Description

Other Exchanges 00775:Hong Kong
Address 2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG
CK Life Sciences International Holdings Inc is an international life sciences company. It is engaged in research and development, manufacturing, commercialization, marketing and selling of health and agriculture-related products, as well as investment in a portfolio of vineyards, and various financial and investment products. Its pipeline includes Seviprotimut-L, TTX-MC138, Seviprotimut-L + TTX-MC138, TTX-RIGA, Halneuron, among others. Its segments include Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D with the majority of the revenue deriving from Nutraceutical segment. Geographically it operates in Asia Pacific that derives the majority of the revenue and North America.
34GF Score

Get the complete analysis for FRA:LSI

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.06
Price
€0.08
GF Value